We are live on ! Find out more
NXTC icon

NextCure

44 hedge funds and large institutions have $161M invested in NextCure in 2019 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

3.95% more ownership

Funds ownership: 0%3.95% (+4%)

Holders
44
Holders Change
+44
Holders Change %
% of All Funds
0.96%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
44
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

NXTC Hedge Fund Activity: Q2 2019 in Review

44 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q2 2019, worth a combined $161M.

Buyers outnumbered sellers: 44 funds opened new NXTC positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $47M.

  • 44 institutional investors held NextCure (NXTC) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $161M of NextCure stock for Q2 2019.
  • 44 funds opened new NextCure positions in Q2 2019 and 0 closed out, a net change of +44 holders.
  • The largest NextCure buyer in Q2 2019 was OrbiMed, an estimated $47M added.

Based on aggregated 13F filings for Q2 2019.